124 related articles for article (PubMed ID: 11173587)
1. Effect of Ribonuclease A and Deoxyribonuclease I on Immunostaining of Ki-67 in Cultured Melanoma Cells.
Benfares J; Tourneau AL; Audouin J; Szekeres G
Pathol Oncol Res; 1996; 2(1-2):63-65. PubMed ID: 11173587
[TBL] [Abstract][Full Text] [Related]
2. Effect of ribonuclease A and deoxyribonuclease I on immunostaining of Ki-67 in fixed-embedded sections.
Szekeres G; Le Tourneau A; Benfares J; Audouin J; Diebold J
Pathol Res Pract; 1995 Feb; 191(1):52-6. PubMed ID: 7544466
[TBL] [Abstract][Full Text] [Related]
3. MIB-1 immunostaining on cytological samples: a protocol without antigen retrieval.
Kirbis IS; Flezar MS; Krasovec MU
Cytopathology; 2004 Jun; 15(3):154-9. PubMed ID: 15165272
[TBL] [Abstract][Full Text] [Related]
4. A cautionary note regarding the application of Ki-67 antibodies to paraffin-embedded breast cancers.
Gee JM; Douglas-Jones A; Hepburn P; Sharma AK; McClelland RA; Ellis IO; Nicholson RI
J Pathol; 1995 Nov; 177(3):285-93. PubMed ID: 8551391
[TBL] [Abstract][Full Text] [Related]
5. Comparison of immunostainings for proliferating cell nuclear antigen and Ki-67 in human extraocular lesions.
Kodama T; Kawamoto K; Kono T; Shibuya Y; Setogawa T
Graefes Arch Clin Exp Ophthalmol; 1997 Dec; 235(12):767-72. PubMed ID: 9439969
[TBL] [Abstract][Full Text] [Related]
6. New Ki-67-equivalent murine monoclonal antibodies (MIB 1-3) generated against bacterially expressed parts of the Ki-67 cDNA containing three 62 base pair repetitive elements encoding for the Ki-67 epitope.
Key G; Becker MH; Baron B; Duchrow M; Schlüter C; Flad HD; Gerdes J
Lab Invest; 1993 Jun; 68(6):629-36. PubMed ID: 7685843
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections.
Cattoretti G; Becker MH; Key G; Duchrow M; Schlüter C; Galle J; Gerdes J
J Pathol; 1992 Dec; 168(4):357-63. PubMed ID: 1484317
[TBL] [Abstract][Full Text] [Related]
8. Correlation between nucleolar organizer region staining and Ki-67 immunostaining in human gliomas.
Hara A; Hirayama H; Sakai N; Yamada H; Tanaka T; Mori H
Surg Neurol; 1990 May; 33(5):320-4. PubMed ID: 1691866
[TBL] [Abstract][Full Text] [Related]
9. A comparison of nucleolar organizer region staining and Ki-67 immunostaining in non-Hodgkin's lymphoma.
Hall PA; Crocker J; Watts A; Stansfeld AG
Histopathology; 1988 Apr; 12(4):373-81. PubMed ID: 2453436
[TBL] [Abstract][Full Text] [Related]
10. Cell proliferation in prostatic carcinoma: comparative analysis of Ki-67, MIB-1 and PCNA.
Hepburn PJ; Glynne-Jones E; Goddard L; Gee JM; Harper ME
Histochem J; 1995 Mar; 27(3):196-203. PubMed ID: 7797424
[TBL] [Abstract][Full Text] [Related]
11. Preribosomal ribonucleoprotein particles are a major component of a nucleolar matrix fraction.
Olson MO; Wallace MO; Herrera AH; Marshall-Carlson L; Hunt RC
Biochemistry; 1986 Jan; 25(2):484-91. PubMed ID: 3955008
[TBL] [Abstract][Full Text] [Related]
12. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67.
Gerdes J; Lemke H; Baisch H; Wacker HH; Schwab U; Stein H
J Immunol; 1984 Oct; 133(4):1710-5. PubMed ID: 6206131
[TBL] [Abstract][Full Text] [Related]
13. Ki-67 immunostaining in uveal melanoma. The effect of pre-enucleation radiotherapy.
Mooy CM; de Jong PT; Van der Kwast TH; Mulder PG; Jager MJ; Ruiter DJ
Ophthalmology; 1990 Oct; 97(10):1275-80. PubMed ID: 2243677
[TBL] [Abstract][Full Text] [Related]
14. Differences in cell proliferation and prognostic significance of proliferating cell nuclear antigen and Ki-67 antigen immunoreactivity in in situ and invasive carcinomas of the extrahepatic biliary tract.
Lee CS
Cancer; 1996 Nov; 78(9):1881-7. PubMed ID: 8909306
[TBL] [Abstract][Full Text] [Related]
15. INTRAMITOCHONDRIAL FIBERS WITH DNA CHARACTERISTICS. II. ENZYMATIC AND OTHER HYDROLYTIC TREATMENTS.
NASS S; NASS MM
J Cell Biol; 1963 Dec; 19(3):613-29. PubMed ID: 14086139
[TBL] [Abstract][Full Text] [Related]
16. Immunoelectron-microscopic localization of a proliferation-associated antigen Ki-67 in MCF-7 cells.
Isola J; Helin H; Kallioniemi OP
Histochem J; 1990 Sep; 22(9):498-506. PubMed ID: 2262344
[TBL] [Abstract][Full Text] [Related]
17. Evolutionary conservation in various mammalian species of the human proliferation-associated epitope recognized by the Ki-67 monoclonal antibody.
Falini B; Flenghi L; Fagioli M; Stein H; Schwarting R; Riccardi C; Manocchio I; Pileri S; Pelicci PG; Lanfrancone L
J Histochem Cytochem; 1989 Oct; 37(10):1471-8. PubMed ID: 2476477
[TBL] [Abstract][Full Text] [Related]
18. Regional differences in bromodeoxyuridine uptake, expression of Ki-67 protein, and nucleolar organizer region counts in glioblastoma multiforme.
Onda K; Davis RL; Wilson CB; Hoshino T
Acta Neuropathol; 1994; 87(6):586-93. PubMed ID: 8091951
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of Ki-67 antigen immunostaining (MIB-1 monoclonal antibody) in ovarian cancer.
Mita S; Nakai A; Maeda S; Takeshita T
J Nippon Med Sch; 2004 Dec; 71(6):384-91. PubMed ID: 15673959
[TBL] [Abstract][Full Text] [Related]
20. Expressions of proliferation markers (Ki-67, proliferating cell nuclear antigen, and silver-staining nucleolar organizer regions) and of p53 tumor protein in gestational trophoblastic disease.
Kale A; Söylemez F; Ensari A
Am J Obstet Gynecol; 2001 Mar; 184(4):567-74. PubMed ID: 11262454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
